Letters: Where paracetamol fails to help patients
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: The otherwise excellent article by John Emsley on paracetamol and its dangers (21 October) omits one very important fact about paracetamol: it is a very poor anti-inflammatory drug and so differs from aspirin and the other non-steroidal anti-inflammatory drugs.
Thus, though it can bring down body temperature (antipyretic) and is also an analgesic (pain killer) it cannot reduce inflammation. Thus its use as a painkiller where the pain is due to inflammation or tissue damage is probably not very sensible. Once it has been broken down in the body, if the inflammation is still present, the pain will return. Under these circumstances taking too many tablets can easily occur, particularly if the inflammatory response is the cause of the pain.
Professor A S MILTON
Whaddon, Cambridgeshire
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments